<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0305">
 <label>60</label>
 <element-citation publication-type="journal" id="rf9000">
  <person-group person-group-type="author">
   <name>
    <surname>Munoz</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Swamy</surname>
    <given-names>G.K.</given-names>
   </name>
   <name>
    <surname>Hickman</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Agrawal</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Piedra</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>August</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Cho</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Fries</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Safety and immunogenicity of a respiratory syncytial visus fusion (F) protein nanoparticle vaccine in healthy third trimester pregnant women and their infants</article-title>
  <source>J infect Dis</source>
  <year>2019</year>
  <fpage>1</fpage>
  <lpage>13</lpage>
  <comment>Aug 12 [Epub ahead of print]. PMID: 31402384</comment>
 </element-citation>
</ref>
